T1	Participants 13 64	locally advanced or metastatic renal cell carcinoma
T2	Participants 391 480	treatment-naive and cytokine-pretreated patients with advanced renal cell carcinoma (RCC)
T3	Participants 503 574	Adult patients with measurable, locally advanced, and/or metastatic RCC
T4	Participants 899 994	Of 435 patients enrolled, 233 were treatment naive (54%) and 202 were cytokine pretreated (46%)
T5	Participants 1889 1974	treatment-naive and cytokine-pretreated patients with advanced and/or metastatic RCC.
